We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$981M
Cap. Flow
% of AUM
-11.94%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CALL
Teekay
TK
$1.01B
| $361K | ﹤0.01% |
5,800
-12,900
| -69% | -$746K |
|
752
CALL
Motorola Solutions
MSI
$72.3B
| $360K | ﹤0.01% |
5,400
-13,900
| -72% | -$915K |
|
753
PUT
Mastercard
MA
$502B
| $358K | ﹤0.01% |
+4,900
| New | +$364K |
|
|
PVA
754
CALL
DELISTED
PENN VIRGINIA CORP
PVA
| $356K | ﹤0.01% |
21,000
-14,700
| -41% | -$233K |
|
|
BPFH
755
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $354K | ﹤0.01% |
+26,361
| New | +$338K |
|
|
756
PUT
Motorola Solutions
MSI
$72.3B
| $353K | ﹤0.01% |
5,300
-24,600
| -82% | -$1.62M |
|
|
KEG
757
DELISTED
KEY ENERGY SERVICES INC
KEG
| $352K | ﹤0.01% |
+38,444
| New | +$352K |
|
|
NOR
758
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
| $348K | ﹤0.01% |
14,100
-11,160
| -44% | -$279K |
|
759
CALL
Home Depot
HD
$331B
| $345K | ﹤0.01% |
4,300
-5,000
| -54% | -$394K |
|
760
CALL
Ionis Pharmaceuticals
IONS
$8.6B
| $345K | ﹤0.01% |
+10,000
| New | +$315K |
|
761
PUT
Williams Companies
WMB
$87.5B
| $344K | ﹤0.01% |
+5,900
| New | +$273K |
|
762
CALL
Walt Disney
DIS
$167B
| $342K | ﹤0.01% |
4,000
-12,100
| -75% | -$988K |
|
|
SMA
763
DELISTED
SYMMETRY MEDICAL INC
SMA
| $342K | ﹤0.01% |
38,550
+20,401
| +112% | +$178K |
|
|
DTSI
764
DELISTED
DTS, Inc.
DTSI
| $342K | ﹤0.01% |
+18,600
| New | +$340K |
|
765
CALL
MakeMyTrip
MMYT
$5.36B
| $341K | ﹤0.01% |
+9,700
| New | +$247K |
|
|
NEWP
766
DELISTED
NEWPORT CORP
NEWP
| $340K | ﹤0.01% |
18,352
+200
| +1% | +$3.74K |
|
|
VIRX
767
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $336K | ﹤0.01% |
+245
| New | +$284K |
|
768
Benchmark Electronics
BHE
$2.87B
| $335K | ﹤0.01% |
+13,139
| New | +$309K |
|
769
Archer Daniels Midland
ADM
$38.2B
| $334K | ﹤0.01% |
+7,572
| New | +$335K |
|
770
Advanced Energy
AEIS
$11.6B
| $331K | ﹤0.01% |
17,198
-16,828
| -49% | -$344K |
|
771
IDT Corp
IDT
$1.64B
| $331K | ﹤0.01% |
+26,915
| New | +$312K |
|
772
La-Z-Boy
LZB
$1.58B
| $331K | ﹤0.01% |
+14,273
| New | +$353K |
|
|
KERX
773
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $331K | ﹤0.01% |
+21,505
| New | +$305K |
|
774
Unisys
UIS
$209M
| $330K | ﹤0.01% |
13,336
+3,938
| +42% | +$99.5K |
|
|
TCF
775
DELISTED
TCF Financial Corporation
TCF
| $329K | ﹤0.01% |
20,108
+7,009
| +54% | +$112K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.